Susan LI, Peptide Chief Scientist – Asymchem

Susan Li holds a PhD in Polymer Chemistry and Physics from Nankai University and was a postdoctoral fellow at the University of Texas Southwestern Medical Center. She previously held key roles at PolyPeptide Group, Stanford Research Institute, and Sinopep, focusing on peptide APIs and therapeutics. She now serves as Peptide Chief Scientist at Asymchem, overseeing peptide CMC development and manufacturing

As a comprehensive TIDES solution provider, how does Asymchem’s integrated platform create distinct value for clients navigating today’s complex development and supply chain challenges?

Asymchem’s distinct value lies in its deeply integrated end-to-end partnership model which moves beyond fragmented services to offer full accountability from discovery through commercialization. This is critical as sponsors increasingly seek partners who can streamline development complexity and ensure continuity quality and speed throughout the molecule’s lifecycle. Our approach combines dedicated peptide and oligonucleotide platforms with specialized teams capable of designing robust processes for even the most complicated sequences. Furthermore, we secure reliable raw material supply integrating supply chain management directly into our service offering. This covers not only synthesis through to commercial production but also ensures the stability and quality of critical materials like monomers and amino acids mitigating risks associated with today’s fragile global supply chains.